ICU MEDICAL INC (ICUI) Stock Fundamental Analysis
NASDAQ:ICUI - Nasdaq - US44930G1076 - Common Stock - Currency: USD
ICUI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. ICUI has an average financial health and profitability rating. ICUI has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year ICUI was profitable.
ICUI had a positive operating cash flow in the past year.
In multiple years ICUI reported negative net income over the last 5 years.
ICUI had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of -2.24%, ICUI is doing good in the industry, outperforming 69.52% of the companies in the same industry.
The Return On Equity of ICUI (-4.71%) is better than 70.59% of its industry peers.
The Return On Invested Capital of ICUI (2.76%) is better than 69.52% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ICUI is significantly below the industry average of 8.28%.
The 3 year average ROIC (1.36%) for ICUI is below the current ROIC(2.76%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.24% | ||
| ROE | -4.71% | ||
| ROIC | 2.76% |
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
1.3 Margins
The Operating Margin of ICUI (5.25%) is better than 70.05% of its industry peers.
In the last couple of years the Operating Margin of ICUI has declined.
With a Gross Margin value of 35.11%, ICUI is not doing good in the industry: 71.66% of the companies in the same industry are doing better.
ICUI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.25% | ||
| PM (TTM) | N/A | ||
| GM | 35.11% |
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
2. Health
2.1 Basic Checks
ICUI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ICUI has more shares outstanding
Compared to 5 years ago, ICUI has more shares outstanding
The debt/assets ratio for ICUI is higher compared to a year ago.
2.2 Solvency
ICUI has an Altman-Z score of 1.91. This is not the best score and indicates that ICUI is in the grey zone with still only limited risk for bankruptcy at the moment.
ICUI has a Altman-Z score (1.91) which is comparable to the rest of the industry.
The Debt to FCF ratio of ICUI is 12.69, which is on the high side as it means it would take ICUI, 12.69 years of fcf income to pay off all of its debts.
ICUI has a better Debt to FCF ratio (12.69) than 72.73% of its industry peers.
A Debt/Equity ratio of 0.75 indicates that ICUI is somewhat dependend on debt financing.
ICUI has a Debt to Equity ratio of 0.75. This is in the lower half of the industry: ICUI underperforms 72.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.75 | ||
| Debt/FCF | 12.69 | ||
| Altman-Z | 1.91 |
ROIC/WACC0.37
WACC7.44%
2.3 Liquidity
A Current Ratio of 2.59 indicates that ICUI has no problem at all paying its short term obligations.
ICUI has a Current ratio (2.59) which is in line with its industry peers.
ICUI has a Quick Ratio of 1.52. This is a normal value and indicates that ICUI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.52, ICUI is in line with its industry, outperforming 42.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.59 | ||
| Quick Ratio | 1.52 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 32.86% over the past year.
The Earnings Per Share has been decreasing by -5.28% on average over the past years.
ICUI shows a small growth in Revenue. In the last year, the Revenue has grown by 5.44%.
The Revenue has been growing by 13.47% on average over the past years. This is quite good.
EPS 1Y (TTM)32.86%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%34.62%
Revenue 1Y (TTM)5.44%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-6.44%
3.2 Future
The Earnings Per Share is expected to grow by 16.81% on average over the next years. This is quite good.
The Revenue is expected to grow by 2.68% on average over the next years.
EPS Next Y8.83%
EPS Next 2Y15.81%
EPS Next 3Y15.83%
EPS Next 5Y16.81%
Revenue Next Year-4.99%
Revenue Next 2Y-2.87%
Revenue Next 3Y-0.13%
Revenue Next 5Y2.68%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
ICUI is valuated correctly with a Price/Earnings ratio of 15.01.
ICUI's Price/Earnings ratio is rather cheap when compared to the industry. ICUI is cheaper than 85.56% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.48. ICUI is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 13.53, ICUI is valued correctly.
86.10% of the companies in the same industry are more expensive than ICUI, based on the Price/Forward Earnings ratio.
ICUI's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 34.04.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.01 | ||
| Fwd PE | 13.53 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ICUI is valued cheaply inside the industry as 87.70% of the companies are valued more expensively.
ICUI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ICUI is cheaper than 85.56% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.88 | ||
| EV/EBITDA | 11.83 |
4.3 Compensation for Growth
ICUI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as ICUI's earnings are expected to grow with 15.83% in the coming years.
PEG (NY)1.7
PEG (5Y)N/A
EPS Next 2Y15.81%
EPS Next 3Y15.83%
5. Dividend
5.1 Amount
ICUI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
112.85
-17.06 (-13.13%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners102.26%
Inst Owner Change0.35%
Ins Owners1.14%
Ins Owner Change1.25%
Market Cap2.78B
Analysts83.64
Price Target192.02 (70.16%)
Short Float %4.97%
Short Ratio5.49
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.66%
Min EPS beat(2)31.74%
Max EPS beat(2)39.58%
EPS beat(4)4
Avg EPS beat(4)37.3%
Min EPS beat(4)24.67%
Max EPS beat(4)53.22%
EPS beat(8)8
Avg EPS beat(8)27.42%
EPS beat(12)11
Avg EPS beat(12)19.81%
EPS beat(16)15
Avg EPS beat(16)16.98%
Revenue beat(2)2
Avg Revenue beat(2)2.62%
Min Revenue beat(2)2.15%
Max Revenue beat(2)3.09%
Revenue beat(4)4
Avg Revenue beat(4)2.15%
Min Revenue beat(4)0.5%
Max Revenue beat(4)3.09%
Revenue beat(8)5
Avg Revenue beat(8)-0.76%
Revenue beat(12)6
Avg Revenue beat(12)-0.81%
Revenue beat(16)9
Avg Revenue beat(16)-0.06%
PT rev (1m)0%
PT rev (3m)-0.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.21%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.13%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.79%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.37%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.01 | ||
| Fwd PE | 13.53 | ||
| P/S | 1.15 | ||
| P/FCF | 22.88 | ||
| P/OCF | 13.25 | ||
| P/B | 1.4 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.83 |
EPS(TTM)7.52
EY6.66%
EPS(NY)8.34
Fwd EY7.39%
FCF(TTM)4.93
FCFY4.37%
OCF(TTM)8.52
OCFY7.55%
SpS98.34
BVpS80.77
TBVpS-7.48
PEG (NY)1.7
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.24% | ||
| ROE | -4.71% | ||
| ROCE | 3.49% | ||
| ROIC | 2.76% | ||
| ROICexc | 3% | ||
| ROICexgc | 8.54% | ||
| OM | 5.25% | ||
| PM (TTM) | N/A | ||
| GM | 35.11% | ||
| FCFM | 5.02% |
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
ROICexc(3y)1.47%
ROICexc(5y)4.61%
ROICexgc(3y)4.17%
ROICexgc(5y)7.18%
ROCE(3y)1.72%
ROCE(5y)4.32%
ROICexcg growth 3Y-18.09%
ROICexcg growth 5Y-16.18%
ROICexc growth 3Y-37.66%
ROICexc growth 5Y-28.8%
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
F-Score5
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.75 | ||
| Debt/FCF | 12.69 | ||
| Debt/EBITDA | 4.38 | ||
| Cap/Depr | 41.32% | ||
| Cap/Sales | 3.64% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 61.57% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.59 | ||
| Quick Ratio | 1.52 | ||
| Altman-Z | 1.91 |
F-Score5
WACC7.44%
ROIC/WACC0.37
Cap/Depr(3y)41.42%
Cap/Depr(5y)66.41%
Cap/Sales(3y)4.1%
Cap/Sales(5y)5.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.86%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%34.62%
EPS Next Y8.83%
EPS Next 2Y15.81%
EPS Next 3Y15.83%
EPS Next 5Y16.81%
Revenue 1Y (TTM)5.44%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-6.44%
Revenue Next Year-4.99%
Revenue Next 2Y-2.87%
Revenue Next 3Y-0.13%
Revenue Next 5Y2.68%
EBIT growth 1Y157.49%
EBIT growth 3Y-10.08%
EBIT growth 5Y-11.9%
EBIT Next Year38.33%
EBIT Next 3Y19.87%
EBIT Next 5Y18.27%
FCF growth 1Y210.75%
FCF growth 3Y-15.14%
FCF growth 5YN/A
OCF growth 1Y1169.23%
OCF growth 3Y-8.63%
OCF growth 5Y14.9%